TY - JOUR
T1 - Choroidal neovascularization in 111 eyes of children and adolescents
AU - for the Sankara Nethralaya Vitreoretinal Study Group
AU - Rishi, Pukhraj
AU - Bharat, Rekha Priya Kalluri
AU - Rishi, Ekta
AU - Bhende, Muna
AU - Biswas, Jyotirmay
AU - Ahmed, Arshee
AU - Sudharshan, Sridharan
N1 - Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Nature B.V.
PY - 2022/1
Y1 - 2022/1
N2 - Purpose: To describe the clinical features, management, and outcomes of choroidal neovascularization (CNV) in children less than 18 years of age. Methods: This was a retrospective, case control study of 111 eyes of 96 patients. CNV was clinically diagnosed in all patients. Eyes were classified as those that were observed (Controls; Group 1) or those that had treatment (Cases; Group 2). CNV was categorized as regressed, persistent, or recurrent in order to evaluate the anatomical outcomes. Results: Of 96 patients, 68(71%) were male. Mean presenting age was 11.4 ± 3.4 years (median = 11 years, range = 1–17 years). CNV was bilateral in 15(16%) patients. Of 111 eyes, 38 eyes had treatment (Cases) and 73 eyes did not (Natural history group or Controls). Subfoveal CNV was seen in majority of cases (59%). Most common etiology was post-inflammatory (38%), followed by trauma (16%). Eyes were classified as those that were observed (controls; Group 1) or those that had treatment (cases; Group 2). In group 1, spontaneous regression of CNV was seen in 26(36%) eyes and there was no recurrence in this group. In group 2 following treatment, 25(66%) of 38 eyes achieved complete regression at mean 4.9 months and was persistent in 5 eyes. CNV recurrence was seen in 10 eyes with the mean time to first recurrence being 9 months. At presentation, mean best-corrected visual acuity (BCVA) of eyes with subfoveal CNV was logMAR 0.99 that improved to logMAR 0.63 with treatment. Mean follow-up was 17 months. Conclusion: CNV results in significant visual decline in children; most commonly of post-inflammatory etiology. Treatment achieves high regression rates, albeit with limited visual improvement.
AB - Purpose: To describe the clinical features, management, and outcomes of choroidal neovascularization (CNV) in children less than 18 years of age. Methods: This was a retrospective, case control study of 111 eyes of 96 patients. CNV was clinically diagnosed in all patients. Eyes were classified as those that were observed (Controls; Group 1) or those that had treatment (Cases; Group 2). CNV was categorized as regressed, persistent, or recurrent in order to evaluate the anatomical outcomes. Results: Of 96 patients, 68(71%) were male. Mean presenting age was 11.4 ± 3.4 years (median = 11 years, range = 1–17 years). CNV was bilateral in 15(16%) patients. Of 111 eyes, 38 eyes had treatment (Cases) and 73 eyes did not (Natural history group or Controls). Subfoveal CNV was seen in majority of cases (59%). Most common etiology was post-inflammatory (38%), followed by trauma (16%). Eyes were classified as those that were observed (controls; Group 1) or those that had treatment (cases; Group 2). In group 1, spontaneous regression of CNV was seen in 26(36%) eyes and there was no recurrence in this group. In group 2 following treatment, 25(66%) of 38 eyes achieved complete regression at mean 4.9 months and was persistent in 5 eyes. CNV recurrence was seen in 10 eyes with the mean time to first recurrence being 9 months. At presentation, mean best-corrected visual acuity (BCVA) of eyes with subfoveal CNV was logMAR 0.99 that improved to logMAR 0.63 with treatment. Mean follow-up was 17 months. Conclusion: CNV results in significant visual decline in children; most commonly of post-inflammatory etiology. Treatment achieves high regression rates, albeit with limited visual improvement.
KW - Children
KW - Choroidal neovascularization
KW - Eye
KW - Inflammation
KW - Trauma
KW - Uveitis
UR - http://www.scopus.com/inward/record.url?scp=85113294195&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85113294195&partnerID=8YFLogxK
U2 - 10.1007/s10792-021-02018-2
DO - 10.1007/s10792-021-02018-2
M3 - Article
C2 - 34424436
AN - SCOPUS:85113294195
SN - 0165-5701
VL - 42
SP - 157
EP - 166
JO - International Ophthalmology
JF - International Ophthalmology
IS - 1
ER -